product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-NDRG1 (Thr346) Antibody
catalog :
3217S
quantity :
100 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, immunoprecipitation, flow cytometry
citations: 3
Published Application/Species/DilutionReference
  • western blot; mouse
Heller E, Kaska S, Fallon B, Ferguson D, Kennedy P, Neve R, et al. Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area. J Neurochem. 2015;132:243-53 pubmed publisher
  • western blot; human; fig s2c
  • western blot; mouse; fig s2a
Gasser J, Inuzuka H, Lau A, Wei W, Beroukhim R, Toker A. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell. 2014;56:595-607 pubmed publisher
  • western blot; human
Paugh B, Zhu X, Qu C, Endersby R, Diaz A, Zhang J, et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res. 2013;73:6219-29 pubmed publisher
product information
SKU :
3217S
Product-Name :
Phospho-NDRG1 (Thr346) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R, (Mk)
Applications :
Immunoprecipitation
Product-Category :
Developmental Biology
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
46, 48
Host :
Rabbit
Target :
NDRG1 (Thr346) phosphate
Primary-Protein :
NDRG1
Alt-Names :
CAP43,CMT4D,DRG-1,DRG1,Differentiation-related gene 1 protein,GC4,HMSNL,N-myc downstream regulated 1,N-myc downstream-regulated gene 1 protein,NDR1,NDRG1,NMSL,Nickel-specific induction protein Cap43,PROXY1,Protein NDRG1,RTP,Reducing agents and tunicamycin-responsive protein,Rit42,TARG1,TDD5,protein regulated by oxygen-1,tunicamycin-responsive protein
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.